Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rectal Indomethacin to Prevent Post-ERCP Pancreatitis
NCT01774604Phase 3Terminated
- Sponsor
- Dartmouth Health
- Start
- Jan 2013
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of indomethacin in acute pancreatitis (AP), sponsored by Dartmouth Health. Started Jan 2013; status: terminated.
02
Drugs
indomethacin
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on NCT01774604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01774604.